These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 26902725)
1. Development of an Ex Vivo Tissue Platform To Study the Human Lung Response to Coxiella burnetii. Graham JG; Winchell CG; Kurten RC; Voth DE Infect Immun; 2016 May; 84(5):1438-1445. PubMed ID: 26902725 [TBL] [Abstract][Full Text] [Related]
3. Characterization of Early Stages of Human Alveolar Infection by the Q Fever Agent Dragan AL; Kurten RC; Voth DE Infect Immun; 2019 Mar; 87(5):. PubMed ID: 30833339 [TBL] [Abstract][Full Text] [Related]
5. Coxiella burnetii type IV secretion-dependent recruitment of macrophage autophagosomes. Winchell CG; Graham JG; Kurten RC; Voth DE Infect Immun; 2014 Jun; 82(6):2229-38. PubMed ID: 24643534 [TBL] [Abstract][Full Text] [Related]
6. Host pathways important for Coxiella burnetii infection revealed by genome-wide RNA interference screening. McDonough JA; Newton HJ; Klum S; Swiss R; Agaisse H; Roy CR mBio; 2013 Jan; 4(1):e00606-12. PubMed ID: 23362322 [TBL] [Abstract][Full Text] [Related]
7. Vasodilator-Stimulated Phosphoprotein Activity Is Required for Coxiella burnetii Growth in Human Macrophages. Colonne PM; Winchell CG; Graham JG; Onyilagha FI; MacDonald LJ; Doeppler HR; Storz P; Kurten RC; Beare PA; Heinzen RA; Voth DE PLoS Pathog; 2016 Oct; 12(10):e1005915. PubMed ID: 27711191 [TBL] [Abstract][Full Text] [Related]
8. Identification of ElpA, a Coxiella burnetii pathotype-specific Dot/Icm type IV secretion system substrate. Graham JG; Winchell CG; Sharma UM; Voth DE Infect Immun; 2015 Mar; 83(3):1190-8. PubMed ID: 25605765 [TBL] [Abstract][Full Text] [Related]
10. Lysosomal trafficking regulator restricts intracellular growth of Wan W; Zhang S; Zhao M; OuYang X; Yu Y; Xiong X; Zhao N; Jiao J Front Cell Infect Microbiol; 2023; 13():1336600. PubMed ID: 38282619 [No Abstract] [Full Text] [Related]
11. Biogenesis of the lysosome-derived vacuole containing Coxiella burnetii. Kohler LJ; Roy CR Microbes Infect; 2015; 17(11-12):766-71. PubMed ID: 26327296 [TBL] [Abstract][Full Text] [Related]
12. The Coxiella burnetii Dot/Icm system creates a comfortable home through lysosomal renovation. Newton HJ; Roy CR mBio; 2011; 2(5):. PubMed ID: 22010216 [TBL] [Abstract][Full Text] [Related]
13. The SCID Mouse Model for Identifying Virulence Determinants in van Schaik EJ; Case ED; Martinez E; Bonazzi M; Samuel JE Front Cell Infect Microbiol; 2017; 7():25. PubMed ID: 28217558 [No Abstract] [Full Text] [Related]
14. Dot/Icm type IVB secretion system requirements for Coxiella burnetii growth in human macrophages. Beare PA; Gilk SD; Larson CL; Hill J; Stead CM; Omsland A; Cockrell DC; Howe D; Voth DE; Heinzen RA mBio; 2011; 2(4):e00175-11. PubMed ID: 21862628 [TBL] [Abstract][Full Text] [Related]
15. Coxiella burnetii Subverts p62/Sequestosome 1 and Activates Nrf2 Signaling in Human Macrophages. Winchell CG; Dragan AL; Brann KR; Onyilagha FI; Kurten RC; Voth DE Infect Immun; 2018 May; 86(5):. PubMed ID: 29483292 [No Abstract] [Full Text] [Related]
16. Dot/Icm-Translocated Proteins Important for Biogenesis of the Coxiella burnetii-Containing Vacuole Identified by Screening of an Effector Mutant Sublibrary. Crabill E; Schofield WB; Newton HJ; Goodman AL; Roy CR Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29339460 [No Abstract] [Full Text] [Related]
17. Avoidance of the NLRP3 Inflammasome by the Stealth Pathogen, Delaney MA; Hartigh AD; Carpentier SJ; Birkland TP; Knowles DP; Cookson BT; Frevert CW Vet Pathol; 2021 Jul; 58(4):624-642. PubMed ID: 33357072 [No Abstract] [Full Text] [Related]
18. Effector Protein Cig2 Decreases Host Tolerance of Infection by Directing Constitutive Fusion of Autophagosomes with the Coxiella-Containing Vacuole. Kohler LJ; Reed ShC; Sarraf SA; Arteaga DD; Newton HJ; Roy CR mBio; 2016 Jul; 7(4):. PubMed ID: 27435465 [TBL] [Abstract][Full Text] [Related]